靶向 HIV-1 前病毒转录。
Targeting HIV-1 proviral transcription.
机构信息
Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, United States.
Cell & Molecular Biology, Biology, Boston University, United States.
出版信息
Curr Opin Virol. 2019 Oct;38:89-96. doi: 10.1016/j.coviro.2019.07.011. Epub 2019 Aug 29.
Abstract
Despite the success of antiretroviral therapies, there is no cure for HIV-1 infection due to the establishment of a long-lived latent reservoir that fuels viral rebound upon treatment interruption. 'Shock-and-kill' strategies to diminish the latent reservoir have had modest impact on the reservoir leading to considerations of alternative approaches to target HIV-1 proviruses. This review explores approaches to target HIV-1 transcription as a way to block the provirus expression.
摘要
尽管抗逆转录病毒疗法取得了成功，但由于建立了一个长期存在的潜伏储库，使得病毒在治疗中断后会反弹，因此 HIV-1 感染仍然无法治愈。“震撼和杀伤”策略旨在减少潜伏储库，但对储库的影响有限，因此人们开始考虑采用其他方法来靶向 HIV-1 前病毒。本文探讨了靶向 HIV-1 转录作为阻断前病毒表达的一种方法。
相似文献
1
Targeting HIV-1 proviral transcription.靶向 HIV-1 前病毒转录。
Curr Opin Virol. 2019 Oct;38:89-96. doi: 10.1016/j.coviro.2019.07.011. Epub 2019 Aug 29.
2
Block-And-Lock Strategies to Cure HIV Infection.阻断与锁定策略治愈 HIV 感染。
Viruses. 2020 Jan 10;12(1):84. doi: 10.3390/v12010084.
3
Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.残余前病毒储存库：HIV持续存在的高风险因素及分析性治疗中断后病毒反弹的驱动因素
Viruses. 2021 Feb 21;13(2):335. doi: 10.3390/v13020335.
4
Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.新型完整前病毒 HIV-1 DNA 检测方法的序列评估与比较分析。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.01986-20.
5
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.潜伏的人类免疫缺陷病毒 1 型前病毒的低诱导率是治愈的主要障碍。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):13-21. doi: 10.1093/infdis/jiaa649.
6
HIV-1 Proviral Transcription and Latency in the New Era.HIV-1 前病毒转录和潜伏期的新纪元。
Viruses. 2020 May 18;12(5):555. doi: 10.3390/v12050555.
7
Transcription of HIV-1 at sites of intact latent provirus integration.HIV-1 在完整潜伏性前病毒整合部位的转录。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20240391. Epub 2024 Aug 14.
8
Relationship between intact HIV-1 proviruses in circulating CD4 T cells and rebound viruses emerging during treatment interruption.循环 CD4 T 细胞中完整 HIV-1 前病毒与治疗中断期间出现的反弹病毒之间的关系。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11341-E11348. doi: 10.1073/pnas.1813512115. Epub 2018 Nov 12.
9
Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.利用重编程的 CRISPR/Cas9 靶向染色质化和抑制 HIV-1 前病毒转录。
Viruses. 2020 Oct 12;12(10):1154. doi: 10.3390/v12101154.
10
Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure.HIV-1 转录调控中的关键因子：功能性治愈的靶点。
Viruses. 2020 May 11;12(5):529. doi: 10.3390/v12050529.
引用本文的文献
1
HIV-induced membraneless organelles orchestrate post-nuclear entry steps.HIV 诱导的无膜细胞器协调核后进入步骤。
J Mol Cell Biol. 2023 Apr 6;14(11). doi: 10.1093/jmcb/mjac060.
2
Block-And-Lock: New Horizons for a Cure for HIV-1.阻断与锁定：治愈HIV-1的新视野
Viruses. 2020 Dec 15;12(12):1443. doi: 10.3390/v12121443.
3
Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.利用重编程的 CRISPR/Cas9 靶向染色质化和抑制 HIV-1 前病毒转录。
Viruses. 2020 Oct 12;12(10):1154. doi: 10.3390/v12101154.
4
HIV-1 Proviral Transcription and Latency in the New Era.HIV-1 前病毒转录和潜伏期的新纪元。
Viruses. 2020 May 18;12(5):555. doi: 10.3390/v12050555.
本文引用的文献
1
Epigenetic reprogramming of immune cells in injury, repair, and resolution.免疫细胞在损伤、修复和消退中的表观遗传重编程。
J Clin Invest. 2019 Jul 22;129(8):2994-3005. doi: 10.1172/JCI124619.
2
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.序贯 LASER ART 和 CRISPR 治疗消除了部分感染人源化小鼠中的 HIV-1。
Nat Commun. 2019 Jul 2;10(1):2753. doi: 10.1038/s41467-019-10366-y.
3
FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction.FOXO1 转录因子在 T 细胞与 HIV-1 的相互作用中发挥关键作用。
PLoS Pathog. 2019 May 1;15(5):e1007669. doi: 10.1371/journal.ppat.1007669. eCollection 2019 May.
4
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat.二氢考地司他丁 A 抑制 Tat 促进 HIV-1 长末端重复序列异染色质形成。
Epigenetics Chromatin. 2019 Apr 16;12(1):23. doi: 10.1186/s13072-019-0267-8.
5
Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription.乙酰化与伙伴：组蛋白酰化修饰的不断扩展调控染色质和转录。
Essays Biochem. 2019 Apr 23;63(1):97-107. doi: 10.1042/EBC20180061.
6
HIV "shock and kill" therapy: In need of revision.HIV“休克与清除”疗法：需要修订。
Antiviral Res. 2019 Jun;166:19-34. doi: 10.1016/j.antiviral.2019.03.008. Epub 2019 Mar 23.
7
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.HIV-1 缓解后 CCR5Δ32/Δ32 造血干细胞移植。
Nature. 2019 Apr;568(7751):244-248. doi: 10.1038/s41586-019-1027-4. Epub 2019 Mar 5.
8
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.去氢皮质甾酮 A 通过特异性结合 Tat 的无规则碱性区抑制 HIV-1。
mBio. 2019 Feb 5;10(1):e02662-18. doi: 10.1128/mBio.02662-18.
9
Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.CRISPRi 靶点的重复富集和验证（REACT）鉴定蛋白酶体为 HIV-1 潜伏期的关键贡献者。
PLoS Pathog. 2019 Jan 15;15(1):e1007498. doi: 10.1371/journal.ppat.1007498. eCollection 2019 Jan.
10
A BAF'ling Approach to Curing HIV.用 BAF 疗法攻克 HIV.
Cell Chem Biol. 2018 Dec 20;25(12):1441-1442. doi: 10.1016/j.chembiol.2018.12.007.
Zotero 插件